534. The Use of Tocilizumab and Remdesivir in SARS- CoV-2 Patients in El Paso Texas: A Longitudinal Comparative Observational Study

BACKGROUND: Currently, the management of SARS-CoV-2 varies with no definitive clinical guidelines, as scientific evidence across the globe differs in therapeutic options. This study intends to provide some clarity to the insufficient data based on the role of monotherapy with tocilizumab (TCZ) and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Almaghlouth, Nouf K, Anyiam, Felix, Attia, Mohamed, Robinson, Matthew, Shah, Sidra, Haq, Syed, Guevara, Roberto, Antony, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690746/
http://dx.doi.org/10.1093/ofid/ofab466.733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690746/
http://dx.doi.org/10.1093/ofid/ofab466.733

Ejemplares similares